Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:3,4-Dihydroxybenzylamine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004350 AN007261 The metabolic effects of succinylation and desuccinylation of HADHB at lysine 292 Cultured cells Rat Nanchang University Second Affiliated Hospital LC-MS
ST003880 AN006373 Untargeted metabolome analysis of control and disease intervertebral disc tissue Tissue Human Bone disease Ganga Orthopaedic Research and Education Foundation LC-MS
ST003565 AN005858 Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST003179 AN005222 Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST002427 AN003950 Dansylated Human Plasma at Known Light-Heavy Mixing Ratios Blood Human University of North Carolina Greensboro LC-MS
ST001547 AN002577 β-Adrenergic regulation of metabolism in macrophages Macrophages Human Monash University LC-MS
ST000549 AN000837 Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors Blood Mouse Diabetes Mayo Clinic LC-MS
ST000549 AN000838 Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors Blood Mouse Diabetes Mayo Clinic LC-MS
ST000539 AN000819 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000403 AN000643 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
  logo